FDA Repulsed By Shire's Magnetic Promotion Of Vyvanse
This article was originally published in The Pink Sheet Daily
Executive Summary
DDMAC warning letter objects to a promotional magnet that obscures risk information; Bad Ad program draws attention to the tchotchke, which Shire stopped distributing in 2008.
You may also be interested in...
"Bad Ad" Program Set To Expand After Opening Spigot Of Complaints In Year One
In its first year of operation, FDA's "Bad Ad" program succeeded in more than tripling the number of complaints the agency receives about deceptive drug advertising, and now the agency is assessing how best to expand upon the success of the initiative.
"Bad Ad" Program Set To Expand After Opening Spigot Of Complaints In Year One
In its first year of operation, FDA's "Bad Ad" program succeeded in more than tripling the number of complaints the agency receives about deceptive drug advertising, and now the agency is assessing how best to expand upon the success of the initiative.
"Bad Ad" On YouTube Snags Warner Chilcott
DDMAC sends Warner Chilcott a notice of violation letter for a sales representative's YouTube video, which had misleading dosing information and no risk information.